Actelion UK and Ireland

Actelion is a biopharmaceutical company focused on the discovery, development and commercialization of smallmolecule drugs as innovative treatments to serve high unmet medical needs. The company has proven its ability to discover new compounds and to rapidly move them from research through development to commercialization.
The company has its corporate headquarters in Allschwil/Basel, Switzerland where it was founded in 1997. Its shares have been listed on the SIX Swiss Exchange since 2000.
Type: NORMAL
Website: http://www.actelion.com/
 
This website requires Flash Player 9 or later. If you can not view this site you probably need to update your system with this plug-in for your browser.